| Product NDC: | 49281-545 | 
| Proprietary Name: | ActHIB | 
| Non Proprietary Name: | HAEMOPHILUS INFLUENZAE TYPE B STRAIN 1482 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN | 
| Active Ingredient(s): | & nbsp; HAEMOPHILUS INFLUENZAE TYPE B STRAIN 1482 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN | 
| Administration Route(s): | |
| Dosage Form(s): | KIT | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 49281-545 | 
| Labeler Name: | Sanofi Pasteur Inc. | 
| Product Type: | VACCINE | 
| FDA Application Number: | BLA103935 | 
| Marketing Category: | BLA | 
| Start Marketing Date: | 19930330 | 
| Package NDC: | 49281-545-05 | 
| Package Description: | 5 KIT in 1 CARTON (49281-545-05) > 1 KIT in 1 KIT * 5 VIAL, SINGLE-DOSE in 1 CARTON > .5 mL in 1 VIAL, SINGLE-DOSE * 5 VIAL, SINGLE-DOSE in 1 CARTON > .6 mL in 1 VIAL, SINGLE-DOSE | 
| NDC Code | 49281-545-05 | 
| Proprietary Name | ActHIB | 
| Package Description | 5 KIT in 1 CARTON (49281-545-05) > 1 KIT in 1 KIT * 5 VIAL, SINGLE-DOSE in 1 CARTON > .5 mL in 1 VIAL, SINGLE-DOSE * 5 VIAL, SINGLE-DOSE in 1 CARTON > .6 mL in 1 VIAL, SINGLE-DOSE | 
| Product NDC | 49281-545 | 
| Product Type Name | VACCINE | 
| Non Proprietary Name | HAEMOPHILUS INFLUENZAE TYPE B STRAIN 1482 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN | 
| Dosage Form Name | KIT | 
| Route Name | |
| Start Marketing Date | 19930330 | 
| Marketing Category Name | BLA | 
| Labeler Name | Sanofi Pasteur Inc. | 
| Substance Name | |
| Strength Number | |
| Strength Unit | |
| Pharmaceutical Classes |